Model-free approach to quantifying the proportion of treatment effect explained by a surrogate marker.
Safety and Efficacy of Tumor Necrosis Factor Antagonists in Older Patients With Ulcerative Colitis: Patient-Level Pooled Analysis of Data From Randomized Trials.
Robust and efficient semi-supervised estimation of average treatment effects with application to electronic health records data.
